Top Analysts Pick Three Stocks with Significant Upside
ByAinvest
Wednesday, Jul 30, 2025 6:42 am ET1min read
BTDR--
Bitdeer Technologies (BTDR) has received a unanimous Buy rating from all nine analysts covering the stock. The 12-month price target implies a 52.2% upside. Despite recent market concerns and investor apprehensions, the company’s strategic moves, including potential expansion into Europe, have sparked investor curiosity [3].
Edgewise Therapeutic (EWTX) has also received a strong Buy rating from all eight analysts covering the stock. The 12-month price target suggests a 214.6% upside. The company’s innovative approach in the therapeutic sector has garnered analyst attention [3].
Hut 8 (HUT) has been rated a Buy by all 11 analysts covering the stock, with a 12-month price target implying a 31.7% upside. The company’s robust fundamentals and growth potential have contributed to this positive outlook [3].
These recommendations underscore the potential for substantial growth in these stocks. Investors should closely monitor these companies and consider their investment strategies accordingly.
References:
[1] https://www.investing.com/news/analyst-ratings/hc-wainwright-reiterates-buy-rating-on-crinetics-stock-at-81-price-target-93CH-4143703
[2] https://www.stocktitan.net/news/BLZE/
[3] https://www.timothysykes.com/news/bitdeer-technologies-group-btdr-news-2025_05_15/
CRNX--
EWTX--
HUT--
Three stocks to buy now according to top analysts are Bitdeer Technologies (BTDR), Edgewise Therapeutic (EWTX), and Hut 8 (HUT). All 11 analysts covering Hut 8 have rated it a Buy, with a 12-month price target implying a 31.7% upside. Similarly, all nine analysts covering Bitdeer Technologies have rated it a Buy, with a 12-month price target implying a 52.2% upside. Edgewise Therapeutic has all eight analysts rating it a Buy, with a 12-month price target implying a 214.6% upside.
Three stocks have been recommended by top analysts with significant upside potential. According to the latest data, Bitdeer Technologies (BTDR), Edgewise Therapeutic (EWTX), and Hut 8 (HUT) are the top picks.Bitdeer Technologies (BTDR) has received a unanimous Buy rating from all nine analysts covering the stock. The 12-month price target implies a 52.2% upside. Despite recent market concerns and investor apprehensions, the company’s strategic moves, including potential expansion into Europe, have sparked investor curiosity [3].
Edgewise Therapeutic (EWTX) has also received a strong Buy rating from all eight analysts covering the stock. The 12-month price target suggests a 214.6% upside. The company’s innovative approach in the therapeutic sector has garnered analyst attention [3].
Hut 8 (HUT) has been rated a Buy by all 11 analysts covering the stock, with a 12-month price target implying a 31.7% upside. The company’s robust fundamentals and growth potential have contributed to this positive outlook [3].
These recommendations underscore the potential for substantial growth in these stocks. Investors should closely monitor these companies and consider their investment strategies accordingly.
References:
[1] https://www.investing.com/news/analyst-ratings/hc-wainwright-reiterates-buy-rating-on-crinetics-stock-at-81-price-target-93CH-4143703
[2] https://www.stocktitan.net/news/BLZE/
[3] https://www.timothysykes.com/news/bitdeer-technologies-group-btdr-news-2025_05_15/
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet